Skip to content
Israeli caregivers receive 4th dose of Covid-19 vaccine
 | Local News

Israeli caregivers receive 4th dose of Covid-19 vaccine
| News Today | Today Headlines

On December 27, Israeli health workers received a 4th dose of the vaccine. According to the authorities, it will make it possible to evaluate the reaction of the antibodies but also the appearance of possible side effects and more generally its effectiveness against the virus.

Sheba Hospital, located on the outskirts of Tel Aviv, on December 27 began administering a fourth dose of the Covid vaccine to 150 volunteer caregivers who received a third dose more than four months ago and whose amount of antibody seems to have waned. The operation is part of a clinical trial that should precede a national campaign whose launch date has not yet been announced.

The administration of a fourth dose will assess the possible rise in antibodies and the appearance of side effects, and whether or not it reduces the risk of infection, according to Gili Regev-Yochay, director of the infectious disease department of the hospital. Caregivers will be monitored for six months, she said.

Israeli Prime Minister Naftali Bennett said on December 22 that all Israelis over 60 and medical staff would be entitled to a fourth dose, as the country struggles to contain the spread of the Omicron variant, but the decision must still be approved by the Ministry of Health.

Israeli authorities last week tightened travel restrictions to combat the spread of the Omicron variant, adding the United States to its red list of countries to which Israelis are prohibited from traveling. The list, on which France already appeared, includes nearly 70 countries.

Some 4.2 of Israel’s 9.3 million people have received three doses of the coronavirus vaccine. Children between the ages of five and 11 are being vaccinated.

Today Headlines Fox news Israeli caregivers receive 4th dose of Covid-19 vaccine

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.